We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > RTM

News List

Ono Pharma expands drug discovery collaboration with Neurimmune AG ExpressPharma
January 18, 2022
The collaboration focusses on creating antibody drugs against new therapeutic targets in the field of neurodegenerative diseases utilising Neurimmune’s proprietary Reverse Translational Medicine (RTM) technology platform...
Neurimmune and Ono Pharmaceutical extend drug discovery partnership pharmaceutical-business-review
January 18, 2022
Neurimmune and Ono Pharmaceutical have announced the expansion of a drug discovery partnership agreement to develop antibody drugs for neurodegenerative diseases.
Neurimmune, Ono Expand Neurodegenerative Discovery Collaboration contractpharma
January 17, 2022
Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. to create antibody drugs against new therapeutic targets in the field of neurodegenerative diseases using Neurimmune's...